COVID-19: Page 6

Rapid nirmatrelvir treatment in study reduced long-COVID risk
By Elissa Wolfson
Nirmatrelvir treatment soon after a positive SARS-CoV-2 test result may reduce the chances of developing long COVID in people with risk factors.
March 23, 2023
3d Closeup Coronavirus Social
Quest launches long-COVID testing panels for consumers
By LabPulse.com staff writers
The panels could be used by any of the millions of Americans that still suffer from lingering COVID-19 side effects, Quest said.
March 22, 2023
Long Covid Word Cloud Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
By Leo O'Connor
The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.
March 21, 2023
Business Financial Stock Drop Social
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
By LabPulse.com staff writers
People who recover from SARS-CoV-2 infection and then get vaccinated are more protected than people who are unvaccinated, the researchers added.
March 20, 2023
Sars Co V 2 Spike Coronavirus Social
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
By Leo O'Connor
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Fda Button Social
Chicago man indicted for COVID-19 testing fraud
By LabPulse.com staff writers
A Chicago lab that he co-owned obtained more then $83 million from the HRSA Uninsured Program as payment for COVID-19 tests purportedly performed by the laboratory, a U.S. Attorney's Office said.
March 14, 2023
Gavel Resized
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
By LabPulse.com staff writers
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Covid 19 Spread Usa Social
COVID-19 leads to increased chest pain long after infection
By Elissa Wolfson
In an ongoing effort to quantify long COVID’s impacts, nearly 150,000 patients were studied for cardiovascular symptoms following a COVID-19 infection.
March 6, 2023
Chest Heart Pain Social
Artificial intelligence tool identifies current drugs for future pandemics
By Elissa Wolfson
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
Covid 19 Pill Social
COVID-19 vaccine development: Public funding yielded private profits
By Elissa Wolfson
A BMJ study calculated U.S. public investments in pre-pandemic COVID-19 vaccine development and recommended policy reforms to maximize public health benefits.
March 1, 2023
Covid 19 Vaccine Distribution Transport Social
Collaborative research helps long-COVID patients recover
By Elissa Wolfson
An NIH initiative called Researching COVID to Enhance Recovery (RECOVER) joins patients with researchers to better understand and treat long COVID.
March 3, 2023
Long Covid Brain Graphic Social
Immune-response test in study detects COVID-19 with near-perfect accuracy
By Elissa Wolfson
A test that monitors the body’s molecular response to the SARS‑CoV‑2 virus can diagnose even asymptomatic patients with near-perfect accuracy, the researchers said.
March 1, 2023
Coronavirus Covid Blue Social
Previous Page
Page 6 of 35
Next Page